You are here

  • Home
  • Online First
  • Financial conflicts of interest among clinical guideline authors

Article Text

Article menu
Download PDFPDF
DTB select
Financial conflicts of interest among clinical guideline authors

http://dx.doi.org/10.1136/dtb.2023.000025

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Key learning points

    • The Open Payments database lists all payments received by US healthcare professionals from pharmaceutical and medical device companies.

    • An analysis compared details of financial conflicts of interest disclosed by US clinical guideline authors with payments recorded on the Open Payments database.

    • Among 270 US physician authors of clinical guidelines, 74% received payments from industry, but only 37% disclosed financial conflicts of interest.

    A study of financial conflicts of interest (COI) among US authors of clinical guidelines found that COI are common and under-reported.1

    Overview

    This cross-sectional study assessed pharmaceutical and medical device industry-related financial COI information disclosed by authors of US clinical guidelines issued in 2020 and compared it with information contained within the authors’ records held on the US Open Payments (OP) database.1 Only US authors who …

    View Full Text

    Footnotes

    • Contributors DTB Team.

    • Provenance and peer review Commissioned; internally peer reviewed.